摘要 |
Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
|
申请人 |
SMITHKLINE BEECHAM CORPORATION;MARINO, JOSEPH, P., JR.;RYAN, M., DOMINIC;THOMPSON, SCOTT, KEVIN;VEBER, DANIEL, FRANK |
发明人 |
MARINO, JOSEPH, P., JR.;RYAN, M., DOMINIC;THOMPSON, SCOTT, KEVIN;VEBER, DANIEL, FRANK |